FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2274046219> ?p ?o ?g. }

• W2274046219 endingPage "1008" @default.
• W2274046219 startingPage "1000" @default.
• W2274046219 abstract "IgG4-related disease (IgG4-RD) is a relapsing-remitting condition responsible for fibroinflammatory lesions that can lead to organ damage and life-threatening complications at nearly any anatomical site. The duration of remission following treatment varies and predictors of relapse are unclear. The objectives of this study were to review our experience with rituximab as remission induction in IgG4-RD, to clarify the duration of efficacy and to identify predictors of flare following treatment.In this retrospective cohort study, all patients were treated with two doses of rituximab (1 g) separated by 15 days. Clinical, radiographic and laboratory data pertaining to rituximab response and disease relapse were collected from the electronic medical record. Kaplan-Meier curves were constructed to estimate the time to disease relapse. Log-rank analyses were performed to compare times to relapse among subgroups. Potential relapse predictors were evaluated with Cox regression analysis.Fifty-seven of 60 patients (95%) had clinical responses to rituximab. Forty-one patients (68%) were treated without glucocorticoids. Twenty-one patients (37%) experienced relapses following treatment at a median time from the first infusion of 244 days. Baseline concentrations of serum IgG4, IgE and circulating eosinophils predicted subsequent relapses, with hazard ratios of 6.2 (95% CI: 1.2, 32.0), 8.2 (95% CI: 1.4, 50.0) and 7.9 (95% CI: 1.8, 34.7), respectively. The higher the baseline values, the greater the risk of relapse and the shorter the time to relapse. Only 10% of the patients had elevations of all three major risk factors, underscoring the importance of measuring all three at baseline.Baseline elevations in serum IgG4, IgE and blood eosinophil concentrations all predict IgG4-RD relapses independently." @default.
• W2274046219 created "2016-06-24" @default.
• W2274046219 creator A5006798748 @default.
• W2274046219 creator A5018239396 @default.
• W2274046219 creator A5029858737 @default.
• W2274046219 creator A5031679757 @default.
• W2274046219 creator A5038972103 @default.
• W2274046219 creator A5042482253 @default.
• W2274046219 creator A5064877880 @default.
• W2274046219 creator A5069840184 @default.
• W2274046219 creator A5087655468 @default.
• W2274046219 date "2016-02-16" @default.
• W2274046219 modified "2023-10-11" @default.
• W2274046219 title "Predictors of disease relapse in IgG4-related disease following rituximab" @default.
• W2274046219 cites W1946311808 @default.
• W2274046219 cites W1967876046 @default.
• W2274046219 cites W1967906245 @default.
• W2274046219 cites W1971271788 @default.
• W2274046219 cites W1978791492 @default.
• W2274046219 cites W1982245010 @default.
• W2274046219 cites W2013324002 @default.
• W2274046219 cites W2021988356 @default.
• W2274046219 cites W2022213430 @default.
• W2274046219 cites W2035861698 @default.
• W2274046219 cites W2062261476 @default.
• W2274046219 cites W2075300336 @default.
• W2274046219 cites W2082783569 @default.
• W2274046219 cites W2085860489 @default.
• W2274046219 cites W2087669067 @default.
• W2274046219 cites W2100918713 @default.
• W2274046219 cites W2108302885 @default.
• W2274046219 cites W2109475734 @default.
• W2274046219 cites W2110662561 @default.
• W2274046219 cites W2126983369 @default.
• W2274046219 cites W2130373985 @default.
• W2274046219 cites W2139500303 @default.
• W2274046219 cites W2143384479 @default.
• W2274046219 cites W2145093846 @default.
• W2274046219 cites W2148783376 @default.
• W2274046219 cites W2153400655 @default.
• W2274046219 cites W2312861270 @default.
• W2274046219 cites W2614362231 @default.
• W2274046219 cites W3140754719 @default.
• W2274046219 doi "https://doi.org/10.1093/rheumatology/kev438" @default.
• W2274046219 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4900135" @default.
• W2274046219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26888853" @default.
• W2274046219 hasPublicationYear "2016" @default.
• W2274046219 type Work @default.
• W2274046219 sameAs 2274046219 @default.
• W2274046219 citedByCount "141" @default.
• W2274046219 countsByYear W22740462192016 @default.
• W2274046219 countsByYear W22740462192017 @default.
• W2274046219 countsByYear W22740462192018 @default.
• W2274046219 countsByYear W22740462192019 @default.
• W2274046219 countsByYear W22740462192020 @default.
• W2274046219 countsByYear W22740462192021 @default.
• W2274046219 countsByYear W22740462192022 @default.
• W2274046219 countsByYear W22740462192023 @default.
• W2274046219 crossrefType "journal-article" @default.
• W2274046219 hasAuthorship W2274046219A5006798748 @default.
• W2274046219 hasAuthorship W2274046219A5018239396 @default.
• W2274046219 hasAuthorship W2274046219A5029858737 @default.
• W2274046219 hasAuthorship W2274046219A5031679757 @default.
• W2274046219 hasAuthorship W2274046219A5038972103 @default.
• W2274046219 hasAuthorship W2274046219A5042482253 @default.
• W2274046219 hasAuthorship W2274046219A5064877880 @default.
• W2274046219 hasAuthorship W2274046219A5069840184 @default.
• W2274046219 hasAuthorship W2274046219A5087655468 @default.
• W2274046219 hasBestOaLocation W22740462191 @default.
• W2274046219 hasConcept C126322002 @default.
• W2274046219 hasConcept C141071460 @default.
• W2274046219 hasConcept C151956035 @default.
• W2274046219 hasConcept C167135981 @default.
• W2274046219 hasConcept C207103383 @default.
• W2274046219 hasConcept C2779134260 @default.
• W2274046219 hasConcept C2779338263 @default.
• W2274046219 hasConcept C2780224187 @default.
• W2274046219 hasConcept C2780653079 @default.
• W2274046219 hasConcept C44249647 @default.
• W2274046219 hasConcept C50382708 @default.
• W2274046219 hasConcept C71924100 @default.
• W2274046219 hasConcept C72563966 @default.
• W2274046219 hasConcept C90924648 @default.
• W2274046219 hasConceptScore W2274046219C126322002 @default.
• W2274046219 hasConceptScore W2274046219C141071460 @default.
• W2274046219 hasConceptScore W2274046219C151956035 @default.
• W2274046219 hasConceptScore W2274046219C167135981 @default.
• W2274046219 hasConceptScore W2274046219C207103383 @default.
• W2274046219 hasConceptScore W2274046219C2779134260 @default.
• W2274046219 hasConceptScore W2274046219C2779338263 @default.
• W2274046219 hasConceptScore W2274046219C2780224187 @default.
• W2274046219 hasConceptScore W2274046219C2780653079 @default.
• W2274046219 hasConceptScore W2274046219C44249647 @default.
• W2274046219 hasConceptScore W2274046219C50382708 @default.
• W2274046219 hasConceptScore W2274046219C71924100 @default.
• W2274046219 hasConceptScore W2274046219C72563966 @default.
• W2274046219 hasConceptScore W2274046219C90924648 @default.
• W2274046219 hasIssue "6" @default.

• next